Literature DB >> 11916070

Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer.

L H Iversen1, O Thorlacius-Ussing.   

Abstract

In a prospective study, coagulation test results were compared in 137 patients with colorectal cancer (CRC) and 39 subjects with benign colorectal diseases. Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin complex (TAT), and soluble fibrin (SF) were measured in plasma before and after surgery. CRC patients presented with significantly higher values of F1+2 and TAT than controls. Patients with localised CRC had elevated values of F1+2 and TAT, whereas patients with advanced CRC also had elevated SF values. TAT and SF levels correlated with tumour spread, and normal values virtually excluded advanced cancer. Postoperative deep venous thrombosis (DVT) was diagnosed by phlebography in 20% of the CRC patients. Preoperative values of the markers did not predict postoperative DVT, but postoperative values did.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916070

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  Venous thromboembolic disease in colorectal patients.

Authors:  Michael P McNally; Christopher J Burns
Journal:  Clin Colon Rectal Surg       Date:  2009-02

2.  Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response.

Authors:  Hiroharu Yamashita; Joji Kitayama; Masataka Taguri; Hirokazu Nagawa
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

Review 3.  Assessing risk of venous thromboembolism in the patient with cancer.

Authors:  Alok A Khorana; Gregory C Connolly
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

4.  Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.

Authors:  Seth Felder; Morten Schnack Rasmussen; Ray King; Bradford Sklow; Mary Kwaan; Robert Madoff; Christine Jensen
Journal:  Cochrane Database Syst Rev       Date:  2019-03-27

5.  Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.

Authors:  Seth Felder; Morten Schnack Rasmussen; Ray King; Bradford Sklow; Mary Kwaan; Robert Madoff; Christine Jensen
Journal:  Cochrane Database Syst Rev       Date:  2019-08-26

6.  Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer.

Authors:  Hiroharu Yamashita; Joji Kitayama; Nobuko Kanno; Yutaka Yatomi; Hirokazu Nagawa
Journal:  BMC Cancer       Date:  2006-06-01       Impact factor: 4.430

7.  Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.

Authors:  Liangliang Zhao; Yayan Bi; Junjie Kou; Jialan Shi; Daxun Piao
Journal:  J Exp Clin Cancer Res       Date:  2016-03-25

8.  Clinical Significance of Preoperative Thrombin Time in Patients with Esophageal Squamous Cell Carcinoma following Surgical Resection.

Authors:  Xiao-Hui Li; Xue-Ping Wang; Wen-Shen Gu; Jian-Hua Lin; Hao Huang; Ting Kang; Lin Zhang; Hao Chen; Xin Zheng
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

9.  Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.

Authors:  Seth Felder; Morten Schnack Rasmussen; Ray King; Bradford Sklow; Mary Kwaan; Robert Madoff; Christine Jensen
Journal:  Cochrane Database Syst Rev       Date:  2018-11-27

10.  Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer.

Authors:  C C Kirwan; G McDowell; C N McCollum; S Kumar; G J Byrne
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.